top of page

Session Posters CHO 2022

Poster 1 : A CRISPR-inhibition functional screen to identify long non-coding RNAs implicated in the pathophysiology of Multiple Myeloma

Poster 2: Cell quiescence and reprogramming are distinctive features of pre-leukemic stem cells in B-cell acute Iymphoid leukemia

Poster 3: A novel transgenic model to study the stem cells that persist
upon tyrosine kinase inhibitor treatment of chronic myeloid leukemia

Poster 4: Characterization of LPS binding and subsequent activation of normal and malignant B cells through the CD180 receptor

Poster 5: Combined single-cell genotyping and phenotyping reveals underlying TP53 clonal hematopoiesis in adult Iow-hypodiploid ALL

Poster 6: Decoding the molecular role of the aorta microenvironment in HSC generation

Poster 7: Elucidating the role ofN-Acetyl-Aspartate in normal hematopoiesis

Poster 8: Familial genetic study reveals potential AXL involvement in mastocytosis physiopathology and treatment

Poster 10: In vitro expansion and gene modulation of murine HSCs for improvement of immunotherapy against solid malignancies

Poster 11: How studying cell-to-cell gene expression variability could help deciphering endothelial-to-hematopoietic transition

Poster 12: Mesenchymal stem cells (MSCs) from non-fibrotic and fibrotic MPN patients have distinct differentiation capacities that are confirmed by a mnltiomics study unraveling dysregulated pathways.

Poster 13: Methylome-based clustering of mutant IDHI acute myeloid leukemia reveals robust clusters associated with response to targeted therapy.

Poster 14: New insights in mastocytosis physiopathology provided by genetic study of familial forms

Poster 15: Metabolic reprogramming of bone marrow stroma! cells in chronic lymphocytic leukemia

Poster 17: Protein Arginine Methyltransferase 2 is involved in acute myeloid leukemia through its role on inflammation

Poster 18: Fuuctional impact ofWaldenstriim's Macroglobulinemia SPil mutation Q226E on B Iymphopoiesis

Poster 19: Pediatric B-Acute lymphoblastic leukemia mesenchymal stem cells display abnormal functional characteristics disrupting normal hematopoiesis

Poster 20: Stepwise GAT Al and SMC3 mutations alter megakaryocyte differentiation in a Down syndrome leukemia model

Poster 21: The proliferative capacity and differentiation potential of mesenchymal stem and progenitor cells in relation to the expression of aldehyde dehydrogenase and oxidative status

Poster 22: Unravelling the role(s) of micro-environmement in myelodysplastic syndromes: from stroma! cells to human ossicles in mice

Poster 23: What are the signaling pathways downstream of JAM-C that maintain the stemness of LSCs ?

Poster 24: PML physiological fonctions are required for acute promyelocytic leukemia cure, independently from the immune system

Poster 25: SUMOylation Controls AML Cells Migration Through the Regulation of CD36 Gene Expression

Poster 26: The promising role of the linker histone Hl.3 in H3K27me3H/ST/high leukaemia

Poster 27: Alteration of the tumor suppressor PDCD4 by a nove! alternative splicing in acute myeloid Ieukemia

Poster 28: Application of high-dimensional spectral cytometry to the evaluation of drug responses in AML patient samples

Poster 29: Edification of the blood system in the human embryo

Poster 30: Impact of heterochromatin alterations and retrotransposon expression on HSC functional changes and clonai selection in the context of TET2 loss

bottom of page